HUP0300117A3 - Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase - Google Patents

Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Info

Publication number
HUP0300117A3
HUP0300117A3 HU0300117A HUP0300117A HUP0300117A3 HU P0300117 A3 HUP0300117 A3 HU P0300117A3 HU 0300117 A HU0300117 A HU 0300117A HU P0300117 A HUP0300117 A HU P0300117A HU P0300117 A3 HUP0300117 A3 HU P0300117A3
Authority
HU
Hungary
Prior art keywords
aromatase
interleukin
antagonists
treatment
high levels
Prior art date
Application number
HU0300117A
Other languages
English (en)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HUP0300117A2 publication Critical patent/HUP0300117A2/hu
Publication of HUP0300117A3 publication Critical patent/HUP0300117A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
HU0300117A 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase HUP0300117A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (2)

Publication Number Publication Date
HUP0300117A2 HUP0300117A2 (hu) 2003-04-28
HUP0300117A3 true HUP0300117A3 (en) 2005-09-28

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300117A HUP0300117A3 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Country Status (17)

Country Link
US (1) US7160860B2 (hu)
EP (1) EP1261367B1 (hu)
JP (1) JP2003525906A (hu)
KR (1) KR100694005B1 (hu)
AT (1) ATE295735T1 (hu)
AU (1) AU2000233235A1 (hu)
CA (1) CA2400711A1 (hu)
CZ (1) CZ20022760A3 (hu)
DE (1) DE60020269T2 (hu)
DK (1) DK1261367T3 (hu)
ES (1) ES2241583T3 (hu)
HU (1) HUP0300117A3 (hu)
MX (1) MXPA02008697A (hu)
PL (1) PL356846A1 (hu)
PT (1) PT1261367E (hu)
SK (1) SK12412002A3 (hu)
WO (1) WO2001066131A1 (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
WO2008070863A2 (en) 2006-12-07 2008-06-12 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
CA2710142A1 (en) 2008-01-17 2009-07-23 Beat Lechmann An expandable intervertebral implant and associated method of manufacturing the same
BRPI0910325A8 (pt) 2008-04-05 2019-01-29 Synthes Gmbh implante intervertebral expansível
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9282979B2 (en) 2010-06-24 2016-03-15 DePuy Synthes Products, Inc. Instruments and methods for non-parallel disc space preparation
WO2012003175A1 (en) 2010-06-29 2012-01-05 Synthes Usa, Llc Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
WO2014018098A1 (en) 2012-07-26 2014-01-30 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
JP7019616B2 (ja) 2016-06-28 2022-02-15 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー 関節運動式継手を備えた拡張可能かつ角度調節可能な椎間ケージ
US11510788B2 (en) 2016-06-28 2022-11-29 Eit Emerging Implant Technologies Gmbh Expandable, angularly adjustable intervertebral cages
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
WO2001066131A1 (en) 2001-09-13
PL356846A1 (en) 2004-07-12
HUP0300117A2 (hu) 2003-04-28
CA2400711A1 (en) 2001-09-13
US7160860B2 (en) 2007-01-09
CZ20022760A3 (cs) 2003-03-12
EP1261367A1 (en) 2002-12-04
ATE295735T1 (de) 2005-06-15
JP2003525906A (ja) 2003-09-02
DK1261367T3 (da) 2005-09-12
US20050090443A1 (en) 2005-04-28
EP1261367B1 (en) 2005-05-18
DE60020269D1 (de) 2005-06-23
SK12412002A3 (sk) 2002-12-03
DE60020269T2 (de) 2006-01-19
KR20020079984A (ko) 2002-10-21
KR100694005B1 (ko) 2007-03-12
ES2241583T3 (es) 2005-11-01
MXPA02008697A (es) 2003-04-14
PT1261367E (pt) 2005-09-30
AU2000233235A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
HUP0300117A3 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160389A0 (en) Use of flibanserin for the treatment of sexual disorders
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL159771A0 (en) Combinations for the treatment of inflammatory disorders
IL209842A0 (en) Compounds for the treatment of metabolic disorders
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HK1073997A1 (en) Administration of agents for the treatment of inflammation
HK1066534A1 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
IL161041A0 (en) Mch antagonists for the treatment of obesity
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
EP1463527A4 (en) USE OF GAMMAGLOBULIN FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES
EP1536834A4 (en) DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
SI1487828T1 (sl) Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni
GB0004531D0 (en) The treatment of respiratory diseases
EP1399175A4 (en) THERAPEUTIC USE OF RANK ANTAGONISTS
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
HK1070561A1 (en) Use of specific dose of fandaparinux sodium for the treatment of acs
IL161849A0 (en) Use of an ascomycin for the treatment of blepharitis
IL159259A0 (en) Methods using glycosaminoglycans for the treatment of nephropathy

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees